RKDA - Arcadia Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPS-2.6-2N/AN/A
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1111
Avg. Estimate1.43M1.7M4.03M8.3M
Low Estimate800k1.7M3.4M8.3M
High Estimate800k1.7M3.4M8.3M
Year Ago Sales540k1.02M3.19M4.03M
Sales Growth (year/est)164.40%67.00%26.30%106.20%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-2-1.4-2.2-1.6
EPS Actual-2.6-2-1.8-2.2
Difference-0.6-0.60.4-0.6
Surprise %-30.00%-42.90%18.20%-37.50%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate0000
7 Days Ago-2-1.4-8-4.8
30 Days Ago-2-1.4-8-4.8
60 Days Ago-2-1.4-8-4.8
90 Days Ago-2-1.4-8-4.8
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRKDAIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.43
Next Qtr.N/AN/AN/A0.41
Current YearN/AN/AN/A0.21
Next YearN/AN/AN/A0.10
Next 5 Years (per annum)14.96%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A